NovaBridge Biosciences SEC filings NBP
NovaBridge Biosciences has 330 filings in SEC EDGAR's recent list, going back to Jul 29, 2019. Its latest annual report, Form 20-F, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 15, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2023 | — |
| CORRESP | Letter to the SEC | Aug 7, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 27, 2023 | — |
| EFFECT | Filing | Mar 23, 2021 | — |
| EFFECT | Filing | Dec 14, 2020 | — |
| CORRESP | Letter to the SEC | Dec 10, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2020 | — |
| CORRESP | Letter to the SEC | Dec 1, 2020 | — |
| EFFECT | Filing | Jan 16, 2020 | — |
| EFFECT | Filing | Jan 16, 2020 | — |
| SEC STAFF LETTER | Filing | Jan 15, 2020 | — |
| CORRESP | Letter to the SEC | Jan 15, 2020 | — |
| CERT | 8a cert | Jan 14, 2020 | — |
| CORRESP | Letter to the SEC | Jan 14, 2020 | — |
| CORRESP | Letter to the SEC | Jan 14, 2020 | — |
| 8-A12B | Form 8-a12b | Jan 3, 2020 | — |
| CORRESP | Letter to the SEC | Oct 29, 2019 | — |
| DRSLTR | Filing | Oct 4, 2019 | — |
| DRS/A | Filing | Oct 4, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 19, 2019 | — |
| SEC STAFF LETTER | Filing | Sep 12, 2019 | — |
| DRSLTR | Filing | Sep 5, 2019 | — |
| DRS/A | Filing | Sep 5, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2019 | — |
| DRSLTR | Filing | Jul 29, 2019 | — |
| DRS | Filing | Jul 29, 2019 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NBP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Rockville, MD
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1778016
- Former names
- I-Mab (until Oct 28, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.